University of Nebraska Medical Center

DigitalCommons@UNMC
MD Theses

Special Collections

5-1-1969

Clinical applications of LDH isoenzyme determinations
Ronald M. Wachter
University of Nebraska Medical Center

This manuscript is historical in nature and may not reflect current medical research and
practice. Search PubMed for current research.

Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses
Part of the Medical Education Commons

Recommended Citation
Wachter, Ronald M., "Clinical applications of LDH isoenzyme determinations" (1969). MD Theses. 136.
https://digitalcommons.unmc.edu/mdtheses/136

This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It
has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For
more information, please contact digitalcommons@unmc.edu.

The Clinical Applications of LDH Isoenzyme Determinations
by
Ronald M. Wachter

A THESIS
Presented to the Faculty of
The College of Medicine in the University of Nebraska
In Partial Fulfillment of Requirements
For the Degree of Doctor of Medicine

Under the Supervi si on of C. A. McVlhori er, l\i. D.

Omaha, Nebraska
February 1, 1969

1

INTRODUCTION
The appearance in the world literature of increasing numbers of reports dealing with studies of human enzyme determinations attests to the importance experimenters and clinicians
alike are ascribing to enzymology.

Zimmermann (96) states:

"Enzymology, which was born a century ago, has grown vigorously
during the past few decades.

More than 700 organic catalysts have

been identified in the tissues of living organisms.

Approximately

50 of these enzymes have been identified in the plasma to which
they {,L.in access from injured cells, or perhaps from intact cells.
Interest of clinicians in serum enzymes began over 30 years ago
with the demonstrated diagnostiC usefulness of alkaline and acid
phosphatase, and amylase levels.

Despite the clinical usefulness

of these Darameters of disease and the demonstration, during the
next two decades of a number of other enzymes in the serum, clinical and investigative interest in serum enzymology remained sporadic until 1953.

The demonstration in that year of a transaminase

in normal serum and the subsequent observations that increased levels
of this enzyme faithfully reflect disease of the heart, liver, and
other organs, led to an explosive increase in interest in serum
enzymes.
"The use of serum enzymes as diagnostic aids has been largely
empirical, but the values observed in clinical and experimantal
circumstances permit speculative analysis of the factors that control serum enzyme levels in normal and diseased subjects.

Enzyme

levels are determined as 'activity' rather than 'amount' of enzyme
protein, because the relative concentration of coenzymes, potentia tors, and inhi. bi tors may modify the apparent level ........ An
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elegant development in serum enzymology has been the effort to
distinguish the tissue of origin of a serum enzyme which is
ubiquitously distributed in tissue by studying its isoenzymes,,"
\'Vi th

thi,s brief historical background of enzymology in general,

and the reference to the recent development of isoenzymology, in the
lines that follow will be a closer examination of the different
molecular forms of a particular functional enzyme, lactic dehydrogenase (LDH) ..

-
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DEFINITION, STRUCTURE AND CHEMICAL ACTIVITY
Markert (39), in reviewing the literature, noted that the
following enzymes exist in separate molecular forms within single
specific tissues: esterase, ribonuclease, pepsin, chymotrypsin,
trypsin, lysozyme, cytochrome C, xanthine dehydrogenase, malate
dehydrogenase, and lactic dehydrogenase.

Because of this, the

various investigators noted a need to extend the classification of
enzymes beyond that based on substrate specificity alone.

They

proposed the term 'isozyme' to describe the different molecular
forms in which proteins may exist with the same enzymatic specificity.
In the process of glycolysis lactic dehydrogenase (LDH) is the
enzyme which facilitates in a reversible manner the conversion of
lactate to pyruvate and the concomitant conversion of diphosphopyridine nucleotide (DPN) to reduced DPN (DPNH).

Since glycolysis

is a function carried on by all living cells, LDH is present in
these same cells, although its concentration may vary widely from
tissue to tissue.
One of the earliest reports of discovery of the multiple molecular forms of LDH came in

1950 when Meister (44) observed in the

electrophoresis of crystalline beef-heart lactic dehydrogenase, a
faster moving component (A), to which he accounted the whole enzymic
activity, and also a slower moving one that amounted to about
In

15%.

1957 Sayre (64) postulated that "LDH may consist of a single molec-

ular species which can be observed as a number of components representing different states of aggregation as a result of sulfhydryl or
other urotein

interactions~

In the same year Vesell (76) reported

finding three peaks of LDH activity in electrophoretically separated human sera.

Most workers are now agreed that there are five electrophoretically distinct forms of LDR, which are numbered according to their
rates of electronhoretic migration.

Some workers designate the

fastest (+) migrating fraction (heart fraction) LDR-l and the slowest (-) (liver, skeletal muscle) LDH-5, while others utilize the
reverse designation.

This has added great confusion to the subject.

For purposes of clarity this paper will adhere to the nomenclature
recommended by the subcommittee on isoenzymes of the international
Union: "when multiple forms of an enzyme are identified by electrophoretic separation, they should be given consecutive numbers, the
form having the highest mobility towards the anode being nu.1!lbered
one."(4)

See figure 1.
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Figure 1. Electropherogram illustrating LDH
isoenzyme nomenclature. (After Batsakis)(4).
Markert and Appella (38) studied two main electrophoretic bands
and found the constituents of each had a molecular weight of 134,000.
This was later confirmed bv others (16,84).

The two bands differed

slightly in their Michaelis-Menton constants, charge per molecule
and isoelectric pnints.
Cahn and associates (9) reported that most vertebrates have two
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chief categories of T,DH--one predominates in heart, the other in
muscle4

In starch gel electrophoresi s the most posi ti vely moving

portion is the heart type, the most negatively moving the muscle
type.

These two types were found to have widely differing amino

acid composition

(9, 16), electrophoretic mobility on starch grain

and gel, substrate inhibition kinetics and analog oxidation ratio,
and they were found to elicit antibodies in the rabbit that were
non-cross reactive

(9).

The fact that only five bands are found in most well-documented
careful studies suggested there must be some fundamental significance
in this number, which could be explained by the following hypothesis:
LDH from heart is a tetramer, composed of four identical subunits
(HERR); LDR from muscle is also a tetramer, composed of four identical subunits (1~~~).
ferent genes.

Rand M are probably elaborated by two dif-

If both Rand M genes are active in the same cell,

then the primary gene products recombine in some manner in groups of
four, yielding five different molecular species: HRRR, RHRM,
H~,1lJ\f[M,

and MIV!MM.

HR!rr~f

The order of arrangement only affects the antigenic

specificity--the subunits all act independently with respect to substrate inhibition and rate of reaction with DPN analogs.
the five bands

(9, 16, 40, 58, 65).

This explains

Some of these same workers

(2,9)

found that one of the isoenzymes from crystalline LDH prepared from
beef heart could be dissociated into four inactive subunits of equal
molecular weight
chloride.
Markert

(34,000

.:t

2,000)

by treatment with guanidine hydro-

This lent further sup:)ort tetramer hypothesis.

(40)

Later,

showed that a tetramer could be dissociated into mono-

mers by freezing in 1 M NaCl;

on thawing, reassociation into five

functional tetramers in the expected proportions of

1:4:6:4:1 occurred ..
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Further su:)port of this hypothesis came from Nance and a~-::\socia tes

(45)

in the study of a Brazilian fa,nily whose members were found to have an
erythrocyte LDR abnormality, all readily explainable by assuming a
point mutation leading to an alteration of polypeptide chain M.
Sub-bands of LDR isoenzymes have been artificially produced

(17,37,58)

by various chemical means and the explanation of their

production also lends SUP90rt to the tetrameric hypothesis of

L~R

isoenzyme composition.
Antigenic properties were investigated by several workers (21,

46,52).

Plagemann and associates

(52)

demonstrated antibody to

rabbit LDH-l inhibited only trace amounts of LDR-5, and the isoenzymes
intermediate between the slow and fast migrating forms were inhibited
Gregory and associates (21) demonstrated

to an intermediate degree.

selective inhibition of glycolysis by antibody to LDH in homogenates
of rabbit liver, rabbit Vx-2 carcinoma and mouse Ehrlich ascites
carcinoma.

Sodium oxamate was also shown to inhibit LDR in both an-

aerobic and aerobic glycolysis.

Ng and associates (46) demonstrated

an anti-LDR which inhibited glycolysis and protein synthesis in
tumor culture cells but not in normal tissue cells, suggesting that
their anti-LDH may have been selective for malignant cells.
Biochemical studies (1) have demonstrated that various isoenzymes differed in their capacity to oxidize I-lactic acid, d-J.actic
acid, d-l-o\-hydroxy butyric acid, d-I-j)(.-hydroxy caproic acid and
d-l-~-hydroxy

valerie acid.

The techniaues

USe

-,or identifying the LDH isoenzymes have in-

cluded the electrophoretic rate of migration in solid media and the
relative heat stability_

Electrophoretic demonstration of isoenzyme·

activity is accomplished by conversion of neotetrazolium to purple
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Figure 2. Schematic representation of the reactions
involved in localizing LDH isoenzymes after they have
been separated by electrophoresis in a starch gel.
(After 1&lrkert)(39).

formazin by LDH production Qf DPNH, as illustrated in Figure 20
Wroblewski (88) reported that the LDH from human heart muscle
apneared to be more heat-stable than LDH from other tissues, and went
on to propose a simple heat-stable test for isoenzymes.

He found

that ~DH-5 was almost entirely inactivated after incubation at

57°C

for

30 minutes;

LDH-l was not inactivated after incubation at

for

30 minutes;

and that intermediate forms of LDH were inactivated

after incubation at

65°C for 30 minutes.

65°C

Actual enzyme activity

determinations are made by recording the rate of change in the
characteristic absorption spectrums of reduced DPN at

340 mu.

This

activity may either be measured by the declining optical density as
DPNH is diminishing and pyruvic acid concomitantly is being reduced
to lactic acid, or by the increasing optical density as

DF~h

is in-

creasing 1 and the lactic acid concomitantly is being oxidized to

8

pyruvic acid.

The former reaction is favored by the equilibrium of

the system, but the latter reaction permits the use of more stable
reagents.(5)

Strandjord and associates (71) also propose utilizing

the heat-stability test for diagnosis of certain disease states.
Isoenzyme activity may also be altered by cold temperatures,as
Zondag (97) found a total loss of activity in the slower moving

o
isoenzymes when the specimens were stored at -20 C under certain
conditions.

SERuM AND TISSUE PATTERNS OF LDH ISOENZYJvIES
An interesting facet of LDH isoenzymes is the fact that
each tissue :in the body'elaborates these multiple molecular forms
in its own unique pattern; this discovery has been renorted by
numerous workers. (12, 13, 14, 16,
77, 84, 85, 87, 88, 90, 92)

34, 51, 53, 54, 55, 61, 70,

Pfleiderer(5l) found through study

of extracts of numerous human organs of different age that in
the early stage of life all tissues show nearly the same distribution, exhibiting a

m~um

of activity in Band

3, and that

during their development a change to the state of the adult
tissues occurs.

Cahn and associates (9) reported that during

embryonic development the LDH enzymes of chicken breast muscle
shift from enzymes related to H type (LDH-I) through several
intermediate enzyme types and appear in the adult as pure M
type (LDH-5).
The predominance of LDH-l in aerobically functioning tissues
and the predominance of LDH-5 in anaerobically functioning tissues was noted by Cahn and associates (9), Pfleiderer and Wachsmuth
(50) and Fondy and Kaplan (16)~ and led to the formulation of a
hypothesis that the predominance of LDH-5 in anaerobically metabolic tissues was due to its better efficiency in high concentrations under those conditions thEn LDH-l.

Goldman (18)

states that LDH-5 is better able to convert pyruvate to lactate
in the presence of high pyruvate concentration, thus sustaining
glycolytic activity through the replenishment of NAD, which is
required as a hydrogen acceptor in the earlier oxidation of
triosephosphate.

Research of others indicate the only pathway
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in malignant tumors for non-mitocyondrine oxidation of reduced
IlIAD formed from the oxidation of triosephospha te may be through

pyruvate reduction.

There appears to be a change in LDll type

to an enzyme which is geared for pyruvate reduction. In aerobic
tissues where high substate concentrations do not develop, LDH-l
performs more efficiently.

Studies of malignant cells show a

characteristic high rate of aerobic glycolysis resulting in high
rates of lactic acid production.(16~ 18, 19, 20, 22, 61)

Graff

and associates(20), found that tumor culture cells resort to
glycolysis only when the extracellular glucose concentration
exceeds a threshold level of approximately

5

mg% or less, and

become consumers, rather than producers, of lactic acid when
the glucose concentrations fall below the threshold, which suggests
that glycolysis is the cells' defense against a high influx of
glucose.

Gorozhanskaya and associates (19) found negligible

amounts of oxygen and high content of carbonic acid in their study
of malignant effusions.

Fandy and Kaplan(16) found that synthesis

of M subunits (LDH-5) is stimulated by low oxygen tension and
synthesis of H subunits (LDH-I) was not affected.
Vesell's (77) discovery of predominance of LDR·-l in mature
human erythrocytes (which are highly anaerobic tissue cells) was
in contradiction with the above mentioned hypothesis and led to
the formulation of a second theory (78) consistent with the first,
but more general, holding that each LDR isoenzyme fulfills distinctive roles by virtue of its restriction in various regions of
the cell.

Subcellular localizaion of the isoenzymes depends on

their different kinetic properties, as well as on the metabolic
organization of the particles with which they associate. (4)
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Table I in the auuendix is an attempt to sumarize various
workers' demonstrations of the heterogeneity of LDll activity in
human tissues.

Figures 3 and 4 illustrate the findings of one

worker in his investigations of serum and tissue LDH isoenzyme
patterns (88)"
Human tIssue
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Figure 3. LDH isoenzyme
composition of watery extracts of normal human
tissues.(After Wroblewskj
and Gregory) (88)
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Heart muscle is characterized by a predominance of LDH-l, followed in order by LDll-2, LDH-3, LDH-4 and LDH-5.

Liver shows a

preponderance of LDH-5 followed to a much lesser extent by LDH-4,
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LDH-3, LDH-2 and LDH-I.
enzyme pattern.

Skeletal muscle resembles liver in its i80-

Kidney shows a co-dominance of LDH-l and LDH-2,

followed by LDH-3, LDH-4 and LDH-5.
LDH-~

Lung exhibits prevalence of

and to a lesser extent LDH-2 and LDH-4 are seen.

Pancreas

shows a predominance of LDH-3, followed closely by LDH-l and LDH-2.
In granulocytes LDH-5 predominates.
LDH-l and LDH-2.

Erythrocytes are richest in

Starkweather and associates (67) found large

amounts of LDH-5 are associated with the erythroblast nucleus, and
gradually decreasing quantities of this isoenzyme as the cell matures; thus LDH-5 may be a measure of erythrocyte age.

Prostate,

prostatic fluid, bone marrow, thyroid, adrenal, spleen, brain, cervix, skin and stomach isoenzyme patterns are also presented, and
the reader is referred to Table I in the appendix for these isoenzyme patterns as well as the literature references of each.
'Normal human serum exhi bi ts a predominance of LDH-2 (37-55%
of total LDH activitY/' followed in descending order by LDH-l
(23-45%), LDH-3 (8-24%), LDH-4 (1-8%) and LDH-5 (0-4%).

For more

details refer to Table I in the appendix.(25,43,59,74,75,85,87)
A normal diurnal variation has also been demonstrated by Starkweather and associates (70) as shown in Table II of the appendix.
Here they found a general rise in total LDH activity from the 8 A.N!.
B. A., 50, if. Normal adult
Total plasma LD = 300 units I ml.
>-

irJ. .

-~a.: .: .: ;.: .: ;a.-.~ - -I.~

-----'-c=J-........

a. -

LD~

LDJr

LD3

LD Z

Plasma isoenzymes of lactic
.~ehydro9.enase

Figure 4. Serum L~H isoenzyme composition of a normal individual. (After Wro~
lewski and Gregory)(88)&
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basal state;

ryeak total activity (double the basal rate) occurred

at 6 P.M., as did LDH-5, while LDH-l activity was at its lowest
level at this time.

LDH-2 changes paralleled those of LDH-I; LDH-3

and LDH-4 were much less affected.
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ALTERL'i.TIONS IN THE NORMAL SERUM ISO''';NZYFE PATrl'ERN
Enzymes are proteins and as such, are synthesized in their cells
of origin from amino acids, and somehow find their way into the
plasma.

Analysis of plasma, serum or tissue homogenate is not car-

ried out to determine the amount of an enzyme in terms of weight,
but rather the activitl of the enzyme is determined.

Besides being

dependent upon the method of assay, this measured activity is also
dependent upon tll" .\:Jresence, absence, or rela ti ve concentrations of
inhibitors, activators, co-factors, substrate, and finally the
enzyme itself.

Therefore, any alterations in the activity of the

enzyme may be due to alterations in anyone or more of these factors.
Normal breakdown and turnover of tissues is thought to contribute
to most of the enzyme activity in normal serum.(4)

5

Figure

111u8-

trates the factors influencing measured serum enzyme activity.
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Factors influencing measured serum enzyme activity. (Mod-

ified from Batsakis and Hauss.)(4,23)
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Alterations in cell membrane permeability aupear to playa large
part in enzyme release.

Permeability can be varied physiologically,

and changes may be reversible or irreversible.(4)
Tissue injury has long been known to result in serum enzyme
elevations, and on the surface it would appear easy to attribute
these elevations to the altered membrane permeability resulting from
the in,jury.

That other factors may have an important effect on

serum enzyme activity puzzled Wroblewski in 1958 (93) and later (91)
he used the example of glutamic oxaloacetic transaminase (GOT) in
cardiac tissue to present his point.

He agreed that the high activ-

ity of human cardiac tissue compared with the relatively lower activity of an equivalent weight of serum appears to explain in part
the observed significant elevation of serum GOT values after myocardial infarction.

However, not all enzymes present in large

amounts in the cardiac tissue as compared with equivalent amounts
of serum are noted to increase in the serum of patients experiencing myocardial infarction; i.e. tributyrase and cholinesterase.
Experimants with intravenous injection of GOT and LDH into dogs
results in a rapid rise in serum GOT and LDH values, with a return of
these enzyme activities to normal within 1-4 hours.

In the case of

LDH, when serum enzyme activity rises to ten times that of normal,
it returns to normal range of serum activity in 1 hour.

At this

rate of serum enzyme degradation and/or elimination, the LDH content
of the infarcted heart muscle would not appear to be sufficient to
maintain the serum enzyme activity level at 3 to 6 times normal
serum value for a period of

5-7

days.

Human cardiac muscle con-

tains ap;Jroximately 250, 000 units of LDH/ gm. of wet tissue; with
comparable techniClues the serum contains approximately 400 units/Illl.
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One gram of heart tissue would cause an LDH activity of 100 units/mI.
in 2.2 liters of serum.

An LDH increase o~ 1500 units/mI. often

observed in patients with myocardial infarction presupposes the necrosis of 15 gm. of cardiac muscle.

In order to maintain a serum

level of 1500 uni ts/ml., 15 gm. of heart muscle would have to be
destroyed per hour, or 360 gm. /day.

If the serum LilH level were

maintained at about 1500 units or more for 3 days, which is seen
frequently clinically, 10SO gm. of heart muscle would be required,
whereas a normal heart weighs only about 300 gm.

Thus some other

mechanism must be involved to account for the prolonged enzyme
elevations seen.
The report of Hill (27) in 1954 of elevated LDH serum levels
in neoplastic disease has led to investigations of the mechanism
of such an elevation.(3,4l,47,4s,62,81)

Mahy (41) reports earlier

workers presented evidence that enzymes are removed from the blood
by the reticuloendothelial system.

His work and others'(3,62,4s)

with mice infected with certain strains of Riley virus showed that
the resultant LDH serum elevations were most likely due to decreased
clearance rates from the

~asma.

The possibility that in other

disease states the enzyme serum clearance rate may be decreased
certainly is worthy of some consideration.
The role of necrosis in enzyme elevation was further studied
by'Hroblewski (93) and';Iest (81).

They both found increased levels

of LDH in the absence of necrosis of malignant tumors in rats,
suggesting that increased synthesis, altered membrane permeability
or some other factors must

~lay

a role in the elevation of LDH.

Hause (23) has reported that enzyme elevations in cases of
surgery, infectious diseases, and nulmonary 6mbolism react in the
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the same manner as in myoc::lrdial infarction; quantitative and temporal differences may
nan-specific.

exist~

but the reaction remains the same--

These enzyme changes occur along wi tIl other comrilon

non-specific symptoIDs--rise in temperature, leukocyte

increase~

changes in the CBC, serum protein, UA, increased erythrocyte sedimentation rate, blood sugar and rest nitrogen elevation and other
symptoms which together Hauss has termed the Il acute syndrome. 1t
If the foregoing is true, if there are so many variables to
consider to account for serum enzyme elevations, can any clinical
use be made of enzyme determinations?

tlTroblewski (89) speaks well

to this question: IlMost if not all enzymatic reflections are nonspecific in that more than one etiologic factor and more than
one anatomic site can account for similar quantitative and or
serial enzyme changes.

In addition, the multiplicity of enzymes

present in body' fluids, as well as the influence of other body
fluid constituents, such as inhibitors, antienzymes, activators,
competitors, drugs and others, may account for apparent artefacts
included in the extensive enzyme activity of the body fluid.
However, the concomitant measurement of several enzymatic activities and clinical correlation makes it possible at times to pinpoint the type and site of a pathologic process.

In addition, in

some instances, serum enzyme changes have permitted recognition
of disease such as hepatitis in the prodromal phase of the malady;
in other instances, such as drug toxiCity, serum enzyme alterations
have indicated pathologic effects at a time when other labOratory
parameters have been uninfl1Jenced; in the case of suspected myocardial infarction associated with bundle branch block of other
masking electrocardiographic aberrations, serum enzyme changes may
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contribute pivotally to the resolution of the diagnostic problem.
The use of body fluid enzymes to supplement cytologic techniques
is an addition to the armamentarium for the study of patients with
oncologic diseases •..•. "
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LDH ISOENZYME

.~LTERATIONS

IN DISEASE STATES

Initial enzymatic studies in disease states showed gross
elevations in LDH, SGOT, and others. (92, 83, 82,
31, 30, 28, 24,

6).

47, 79, 74, 63,

As was stated before, all organs contain

LDH, and organ injury produces an elevation in serum LDH; however, this elevation is non-specific.

Cohen (10) proposed that

if some characteristic feature of LDH could be identified that
would betray its source, the locus of specific organ injury might
be established.

With the discovery of the multiple molecular

forms of LDll, identifiable by electrophoretic separation, heat
fractionation, and other means, such a characteristic feature was
found.

Cohen's work, plus that of others discussed below, showed

that the serum pattern of LDll isoenzymes following organ injury
is usually characteristic of that organ.
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ISOEN'ZYMES AND NfYOCAI-mIAL INFARCTION
Cardiac muscle has a predominance of LDE-l and 2, and thus
injury to this tissue results in increases in serum LDH-l and 2.
This increase has been noted within hours (87, 90,

91) of the

onset of the acute attack, is maximal before the fifth postinfarction day, and remains elevated for 5-10 days after all
total plasma enzyme activities have returned to normal range.
(87, 90)

Typical serum LDH isoenzyme patterns in patients with

acute myocardial infarction are reported by Reusch and Bunch (59)
as shown in Table III of the appendix.
predominance of LDH-l.

In all there was a

In two cases SGOT and total LDE changes

were subtle, but isoenzyme analysis clearly demonstrated a shift
from the normal predominance of LDH-2.
Wroblewski and associates (90) demonstrated the serial

LDH

isoenzyme changes in acute myocardial infarction as shown in
Table IV of the appendix.

They presented two patients whose LDH-l

abnormalities persisted for 19 and 20 days.

These abnormalities

are further illustrated by the report of Nutter and associates (49).
See figure 6.

SERIAL CHA.NGES IN LDH-l TN ACUTE MYOCARDIAL INl<'ARCTION
Day

1

2

3

4

5

6

Subjects

8

18

22

22

23

Abnormal

5

17

22

22

Normal

3

0

0
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Figure 6.
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17
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1

1

1

1

2

7

Data showing serial LDH-l changes in acut'e myo-

cardial infarction. (After Nutter)(49).

I
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starkweather (70) studied LDH levels serially on 25 controIs monthly for 9 months and found insignificant variations in
individual enzyme levels even though a wide range of activity was
• observed for the group.

Therefore it appeared to him that normal

serum LDH ranges as derived from statistical data could lead to
erroneous clinical

interpretati~n.

For example, if a person with

a normal LDH level of 0.192 units shows a level of 0.384 units,
statistical data would place it within normal range when actually
a two-fold increase has occurred.

Since baseline determinations

are usually not available, he proposes one should get three fasting samples and evaluate the changes.

The examples in figure

7

illustrate this point.

Basoline
serum

LDH
infarction

4th day

LDH
.130
.144
.082
.178

.360

til'

lin

""

Figure 7.

Difference

serum

Chart show"ing small but significant isoenzyme changes

from base line levels.

(After Starkweather)(70).

In some instances, myocardial infarction may not be accompanied by diagnostic serum enzyme changes, but analysis of the
LDH isoenzyme pattern helps pin down the diagnosis, as illustrated
by the case in figure 8. (74)

22

3! _-_
.~L

Figure 8. Case illustrating insignificant total LDH changes
but significant isoenzyme alterations.

(After Van Der Hel~74).

The serial determination of LDH isoenzymes may also be of
help in diagnosing myocardial infarction which has occurred
several days before medical attention is sought, as illustrated

9. (74)

by figure

Acute Attack 8 Days Before Rosuital Admission

9
12
Figure

9.

Chart showing LDR isoenzyme alterations in a patient

suffering a myocardial infarction eight prior to medical attention.
(After Van Der Helm) (74).

Thus it would appear from the data presented that prolonged
changes in LDF-l occur in uatients with acute myocardial infarction
and that the serial analysis of LDH-l is a sensitive aid in the
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diagnosis of acute myocardial infarction.
It must be Dointed out that in some cases of acute myocardial infarction, there has been noted a rise in LDH-5; this
change has been ascribed to the presence of severe congestive
heart failure, causing increased serum contributions from the
hepatic cells. (87, 73)
Of particular importance is the negative value of the "zymoII

gram.

Thus LDH isoenzymes can be used to differentiate between

myocardial infarction and other conditions not readily distinguishable from myocardial infarction.

Cardiovascular diseases

with normal fractions of LDH-l and LDH-2 include: congestive
heart failure, in all but severe cases,; acute pericarditis;
paroxysmal atrial fibrillation with stenocardia; chronic angina
pectoris, heart block with Stokes-Adams seizures; acute venous
thrombosis of the lower extremity; and pulmonary embolism.

(74,

87, 11, 73)

Starkweather and associates (70) attempted to prognosticate
the clinical course of the patients with myocardial infarctions
on the basis of enzyme studies.

They found that there was no

correlation between serum LDH levels and mortality •. They did,
however, find some relationship with survival and an elevation
in LDH-5 within 24 hours post-infarction_" Twelve such individuals
exhibited a rapid rise in that fraction within 24 hours and did
not recover from the attack.

It is usual to attribute such rises

in LDH-5 to some degree of congestive heart failure; however in
these twelve patients, post mortem examination showed no congestion of the liver, and the source of the LDE-5 was not found
in these cases.

24
Although the agar gel electrophoresis method of determination
is the one used by a great number of workers, it is somewhat
cumbersome.

Wroblewski (88) realized this early and proposed

a simple heat-stable test for determination of LDH isoenzymes.
This determination takes advantage of the fact that different
LDH isoenzymes have different thermolability properties •• lsoenzymes which migrate electrophoretically with the gamma globulins are relatively thermolabile ••• lsoenzymes which migrate
toward the anode (rapidly migrating) are relatively thermostable.
LDH which remains after incubation at 65° C for 30 minutes has
been defined as "heat stable LDH" and represents LDH-l activity.
This quick method of isoenzyme determination in the diagnosis
of myocardial infarction has several proponents. (5, 71, 88)
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ISOENZYMES Hi BEP1\.TIC DISEASE

HEP./\.TITIS

''lieme and Van Maer-eke (85) noted elevations in

rat sera of LDH-5 after experimental induction of liver necrosis
with carbon tetrachloride.

Trujillo and assooiates (73) noted

in four cases of infectious hepatitis an elevation in total LDll
in all, elevated LDH-5 in all, elevated LDE's 2, 3, 4 in two of
the four, and no abnormality in LDH-I.

Vesell (77) noted most

of the LUH activity in sera of patients with hepatitis was in
I,DH's 4 and 5.

1Jfatoole and Novak (43) found in the stud;,\, of four

cases of acute infectious hepatitis an elevation in LDH's

5.

4 and

Cohen (10) reports an LDll isozymogram in a oatient with

hepatitis: LDH-l=18%; LDH-2=27%; LDH-3=9%; LDH-4=8%; LDH-5=38%.
CIRRHOSIS

Matoole and Novak (43) studied 35 cases of Laennec's

cirrhosis and found the most frequent enzyme alteration to be
elevations in LDH's 5 and 4.

Trujillo and associates (73) found

LDH-I elevations in 9 of 15 patient s with cirrhosis, and J,Dll-l
elevations in 2.
BILIARY OBSTRUCTION

Wright and associates (87) studied 10

patients with biliary obstruction and found absolute increases
in LDll-4 and LDll-5 with the elevations of LDH-4 being greater than
those of LDll-5.

This is in contrast to the marked relative in-

creases in LDH-5 seen in hepatocellular damage.

Trujillo and

associates (73) and :N1atoole and :Novak (43) merely found elevations
in LDH-5 or LDH's 5 and 4.
HEPATIC METASTASES AND 1° HEPATOMA
metastases and 1 case of 1

0

In 14 cases of hepatic

hepatoma, Trujillo and associates (73)

found elevated total LDll in 14 of 15, elevated LDH-5 in all 15,
elevated
15.

LDH~2,

3, 4 in 12 of 15, and LDH-l elevations in 10 of

In all the :9redominant isoenzyme was LDH-5.
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Thus, in most cases of liver disease studied the LDH abnormality most often encountered was that of elevation of the
predominant isoenzyme found in hepatic cells, LDH-5.
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ISOENZYMES

nr

PULMONt:cRY E!,;LBOLISM

In 1961 Wacker and associates (19) 'oroposed a !!triad for
the diagnosis of pulmonary embolism and infarction" which included serial measurements of serum LDH, SGOT, and bilirubin.
In 11 patients they renorted consistently elevated LDH, and
consistently normal SGOT in the first four days nost embolism.
Twelve of the 17 had significantly increased bilirubin.

Batsakis

and Briere (4) also reported consistent elevation of serum LDH
in patients with pulmonary infarcts, but could not improve diagnostic accuracy with concomitant serial determinations of SGOT
and bilirubin.

They noted that pulmonary emboli in a hospital

population usually occur as complications of some other disease
and the associated disease not infrequently influences enzyme
levels.

Their most successful method of diagnosis of pulmonary

embolism was with the use of CPK (creatine phosphokinase) determina tions o.r',DH isoenzyme determinations.

Isoenzyme; al terations

included an increased total activity pattern and a relatively
greater prominence of LDH-3.

These changes were attributed to a

combination of effects of hemorrhage (LDH-l and LDH-2) and pulmonary necrosis (LDH-3).

On the second day following infarct,

the majority of patients studied also showed an increase in LDH-5
related to accompanying congestive heart failure and anoxemia of
the centrilobular portions of the liver.
Tru~illo and associates (73) studied 26 patients with pul-

monary embolism and found normal total LDH in H3 patients, and
only minimal increases in the remaining eight.
find alterations i"1 ~}Oe LDH-2, 3, 4 fraction.

However, he did
(Their method of

LDH isoenzyme determination involved heat fractionation in 'i'lhich
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the activities of LDH-2, 3~ and 4 could not be differentiated.)
See figure 10.
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(After Trujil1o)(73).

Although the data from this study do not demonstrate highly consistent LDH-2, 3, 4 alterations, these workers found the
main value of LDH isoenzyme determinations in pulr:lOnary embolism
to be the ability to exclude myocardial infarction and to appraise
other disorders as possible sources of enzyme alteration.
Cohen and his workers (11) studied 19 cases of pulmonary
embolism.

Twelve of those were found to have normal serum total

L1JH; four of these had elevated LDH-I, and eieht were normaL
Seven had elevated serum total LDH; three had elevated LDH-3;
three had elevated LDH-l and 2, and one had elevations of LDH1,2, and

3.

They concluded that the LDH abnormalities that

developed appeared to be related to associated disorders of the
liver or heart.
From the above it would appear that pulmonary embolism may
or may not be accompanied by elevations in total LDH or LDH-3,
but that the main use of LDH isoenzymes would be to exclude myocardial infarction.
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LDH ISOENZYJ\IES IN ANEMIA
In 1958 Zimmerman and his workers (95) reported elevated
serum levels of LDH in patients with megaloblastic anemia, sickle
cell disease, hemoglobin S-C disease, S-thalassemia, and Hemoglobin
A-S or A-C disease.

These alterations were thought to represent

hemolysis, hepatic necrosis, or inherently high LDH concentrations
in primitive marrow cells.
Wright and associates (87) studied four patients with untreated pernicious anemia, 1 with paroxysmal nocturnal hemoglobinuria, 2 with sickle cell anemia, and 1 with idiopathic hemolytic anemia, and found almost equal absolute increases in LDH-l
anct I.DH-2 and a concomitant reduction in the remainder of the
fractions.

This pattern is similar to patterns of red blood cell

hemolysa tes reported earlier.

!J.'hus it would appear that any

hemolytic process would result in increases in LDH-l and LDH-2
in the serum.
Starkweather and associates (67) reported large amounts of
LDH-5 were associated with erythroblast nuclei, and that gradually decreasing amounts of this enzyme were found as the cells
matured, suggesting that LDH-5 may be an indicator of erythrocyte
age; the LDH in aged erythrocytes was found to be LDH-l.

They

propose that when erythrocyte isoenzymes from patients with
hematologic disease are assayed, increases in LDH-5 indicate active or hyperactive erythroid tissue, and absence of this fraction
suggests nonfunctioning tissue.

An increase in the relative per-

centage of LDH-l suggests the presence of an older cell popUlation.
Heller and co-workers (24) studied serum isoenzymes in
patients with megaloblastic and blood loss anemias and found evi-
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dence to supnort the hypothesis that the high plasma levels of
enzymes originated in the bone marrow.
Thus, in the presence of hemolysis there are elevations of
LDH-l, in megaloblastic or hyperplastic marrow conditions there
are elevations of LDH-5, and in aplastic marrow conditions there
is essentially no LDH-5.
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ISOENZYIViES IN MUSCULAR DISORDE-qS
Normal skeletal muscle has a predominance of LDH-5 and thus
one would predict some alterations of this enzyme in skeletal
muscle disorders~

Wright and associates (87) report marked

transient increases in LDH-5 in nine patients suffering crushing trauma, hip fractures, or undergoing extensive surgical
procedures involving muscle.
The effect of exercise on the serum enzyme composition
was studied by Swaiman and Award

(72).

It was postulated that

heavy exercise would result in muscle cell damage which in turn
would result in enzyme release.

However, after studies on 11

men during and after strenuous and prolonged exercise, only
slight increases in aldolase, CPK, SGOT, and LDH were found,
and in some no changes or even decreases in enzyme activity were
found.
Starkweather and associates (69) studied the effect of
artificially induced hemostasis by placing a tourniquet on the
patient's arm for five minutes, after which blood was withdrawn and a three fold increase in LDH was found.

Fifteen

minutes after the pressure release, the serum LDH had almost
returned to base line levels, but an elevation in LDH-5

remain~d.

Emery (15) studied carriers and patients with Duchenne type
pseudohypertrophic muscular dystrophy.

He found no significant

differences in the serum LDH isoenzyme patterns between healthy
children and affected children; also he found no differences
between normal women and carriers.

However, the LDH isoenzyme

pattern of muscle extracts from affected children was very
different from the controls.

LDH-5 appeared to be completely
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absent; this was true in all sta?8S of the disease irrespective
of the grade of severity.
Brody (8) ancl Kelly and associates (36) also re?:)orted finding virtually no LDH-5 activity in sera of pattents with Duchennetype muscular dystrophy_
and neurologic disorders.

However, Brody studied many muscular
His findings are summarized in figure 11.

LDH-5 ABNORIVLil.LITIES IN VARIOUS lIiWSCULAR AND NEUROLOGIC
DISORDER.S
Clinical Diagnosis

No. of Patients
wi th Decreased
LDH-5

Muscular Dystrophy

12

32

Amyotrophic Lateral Sclerosis

6

51

Infantile Spinal Muscular Atrophy

5

5

:Myotonic Dystrophy

4

8

Idiopathic Inflammatory Myopathy

4

18

Dermatomyositis

1

4

Peripheral Polyneuropathy, Idiopathic

3

22

Diabetic Polyneuropathy

1

6

Neuromyopathy(?) Due To Carcinoma

1

3

Spinocerebellar Degeneration

2

7

Charcot-:Marie~Tooth

Disease

2

18

Benign Congenital Hypotonia

1

3

Motor Retardation

1

1

Figure 11.

Total l~o.
of
Patients

Summary of LDH-5 abnormalities in various muscular

and neurologic disorders studied by Brody

(8).

He found the selective decrease in LDH-5 is not restricted
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to patients with muscular dystrophy, but may also be seen in
other myopathies and in diseases primarily affecting neurons.
Acquired as well as hereditary disorders were found to be associated with this phenomenon.

Therefore a decrease in LDH-5 is not

diagnostic of a particular disease entity, it does not differentiate
primary lesions of muscle from neurologic lesions, and it is not
indicative of a hereditary rather than acquired disorder.

This

study did indicate, however, that a deficiency of muscle LDH-5
constitutes a sign of nonspecific abnormality in the neuromuscular
system.
The mechanism for this decrease in LDH-5 in abnormal muscle
has not as yet been adequately explained.
two hypotheses.

Brody (8) suggests

The observation that the activity of the fast-

moving isoenzymes is preferentailly decreased in the presence of
excess lactate suggests that a function of the slow-moving

i80-

enzymes may be to maintain activity in the presence of accumulated
lactate.

Thus the slow-moving isoenzymes participate primarily

in anaerobic (glycolytic) metabolism and the fast moving isoenzymes
participate in aerobic metabolism.

Since the experimental de-

nervation in animals has produced earlier diminution of the glycolytic than of the

oxidative enzymes, it may well be that the

selective reduction of LDH-5 in abnormal muscle may coincide with
the selective reduction of other glycolytic enzymes.
A second hypothesis (8) is based on the observation that the
isoenzyme pattern of normal human fetal muscle also shows a
selective deficit of LDH-5, and that it is possible that low LDH-5
activity in abnormal reflects persistence of or a reversion to a
primitive stage of metabolic adjustment.

ISOENZYhlES IN DISORDERS OF THE GASTROIhTESTINA1 TRACT
Hendrich and Hule (25) studied the serum LDH isoenzymes
of 16 patients with ulcerative colitis and found no substantial
difference from the group of 55 controls.

Homogenates of speci-

mens of rectal mucosa from 8 patients during the acute phase of
ulceration showed high levels of 1DH-5, while specimens of

4

patients in the healing stage or remission showed lower 1DH-5
values.
Prochazka and associates (54, 55) have done work on experimental lesions of the stomach in rats.

In rats with stress in-duced

ulcers, they found increased total LDH activity, as well as
elevated LDH-l,2,3, and
not be explained.

4

with decreased 1DH-5; all of which could

They also performed isoenzyme determinations

on tissue homogenates of normal fundic mucosa, fundic mucosa with
moderate gastritis, fundic mucosa with extensive gastritis, marginal
mucosa of the pyloric peptic ulcer, gastric carcinoma tissue, and
normal pyloric mucosa.

They found progreSSively decreasing amounts

of 1DH-l in the categories previously listed, and found progressively increasing amounts of 1DH-5 in the same categories
tively.

respec-
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DIS}~ASE

LDH ISOEN:6YMFS IK NEOPLASTIC

With the massive amount of research being carried out in
the field of cancer, it is not surprising that a great deal has
been published about LDH isoenzymes by its researchers.
Until Hill and Levi published an article in Cancer Research
in

1954,

(27) the authors had not been able to find any report

of a study of LDH'activity in human serum.

These authors noted

in a study of 51 patients with neoplastic diseases that

49

of

them had elevation of a serum comuonent which catalyzed the
I

~

oxidation of reduced DPN and the simultaneous reduction of
pyruvic acid to lactic acid; in other words, the serum component
referred to as LDH.

White (83) also noted this elevation in

patients with neoplastic disease, and found that it was more
consistently elevated in such patients
pbohexossisomerase

(48%),

aldolase

(16%)

(35%)

than was phos-

or SGOT

(31%).

Most

people in his group with high serum LDH activity had obviously
widespread cancer.

Although Hill (28) later could not sub-

stantiate his earlier findings, the consensus remained that serum
LDll activity was elevated in cancer patients. (6, 18, 82, 34)
In 1957 Vesell and Bearn (76) subjected sera of normal and
"abnormal" patients to starch gel electrophoresis and found three
peaks of LDH activity corresponding to the alpha-I, alpha-2, and
beta serum protein peaks; in three cases of leukemia studied, all
showed elevation in alpha-2 activity relative to the alpha-l peak.
Hsieh and associates (30) demonstrated a d.ecrease in serum LDH
activity in mice bearing squamous cell carcinomas or rhabdomyosarcomas after removal of such tumors, and noted a rise in serum
LDH in the group where the tumors recurred.

The question then arises, what causes the elevated serum

LDH activity in patients with cancer?

Jacobson and Bishio (33)

proposed four hypotheses for the origin of elevated LDH in patients
with cancer: 1) Volume of the tumor reached a critical size such
that the rate of LDH production by the tumor cells was higher
than the normal rate of removal of this enzyme; 2) The tissue
cells which were replaced by the tumor were ruptured or in some
way altered so as to release IDH and other com;Jonents into the
circulatory system; 3) The behavior of normal tissues may be
affected in some manner leading to a release and/or increased
synthesis of the LDH normally present in the organ; and 4) A
factor or virus is often associated with the transmissable tumors
and causes an abnormally high LDR.

Th'ese hy:potheses have been

sunported in whole or in part by other workers (3, 48, 62, 41, 93,

69).
~at

kind of LDH is produced by these tumors?

Richterich

and Burger (61) compared isoenzyme patterns of benign and malignant effusions and found that: 1) In benign effusions (transudates
or inflammatory exudates) the isoenzyme pattern reflected the
serum pattern and the activity of the slowly migrating isoenzymes
was low; 2) In malignant effusions the electrophoretically slowly
migrating fractions were elevated in comparison to the corresponding sera; and 3) The activity of the slowly migrating fractions
was markedly increased independent of the type of malignancy
(carcinoma of the lung, eso:phagus, pancreas and breast; hyperne)Ll'OLLC, reticulosarcoma).
That a high rate of glycolysiS is characteristic of tumor
tissue has long been estab1ished (18, 19, 20).

Ascites fluids
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in cancer patients have been found to have a high content of
carbonic acid, negligible amounts of oxygen , and lactic acid
concentrations two or three times blood levels indicating large
amounts of pyruvate reduction.

Thus, ascttes cells in cancer

cases were found to exist under nearly anaerobic conditions. (19)
!

/

Goldman and associates also found a predominance of, ltDH-5 in
cancerous tissues.

They reported that earlier workers indicated

that the only pathway in malignant tumors for non-rrlitochondrial
oxidation of reduced NAD formed from the oxidation of triosephosphate may be through pyruvate reduction, and that there appearad to be a change in LDH type to an enzyme which is geared for
pyruvate reduction.

Goldman further states that the slowly mi-

grating LDH (M-LDH or LDH-5) nis better able to convert pyruvate
to lamtate in the presence of high pyruvate concentration, thus
sustaining glycolytic activity through the replenishment of NAD,
which is required as a hydrogen acceptor in the earlier oxidation
of triosephosphate.:
Studies of tissue homogenates of various carcinomas have
demonstrated this shift in isoenzyme pattern to increasel amounts
of LDH-5.

Carcinomas studied include those of rectum, colon,

breast, stomach, lung, prostate, kidney, and thyroid, as well as
astrocytomas and malignant tumors of glial origin. (10, 14, 16,

53, 61, 66)
(22, 61)

Studies of malignant effusions also showed this shift.

studies of leukocytes in chronic lymphocytic leukemia

and chronic myelogenous leukemia produced different results;
l:.rmphocytes exhi bi ted relatively low levels of LDH-5 acti vi ty (7.

3%),

whereas granulocytes exhibited high levels of this isoenzyme

(24.1%).

Some workers (68, 87) have found isoenzyme alterations
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of LDH-3 to be the greatest, both in tissue homogenates and in
sera of patients with neoplastic disease.

The only instances of

LDH-5 alterations were in demonstrated cases of hepatic metastases;
when these metastases were shown to be absent, only LDH-3 was
elevated.

However, the majority of workers feel that the main

alteration appears to be in the LDH-5 fraction.
Clinical application of LDH isoenzymes in patients with newplastic disease is useful in several areas.
demonstrate elevated LDH-5

act~vity

from benign effusions. (60, 61)

Malignant effusions

and can thus be differentiated

Following chemotherapy or radiation

therapy, analysis of the effusion could be of prognostic value;
decreases in LDH-5 would indicate effectiveness of the therapy,
and no change or increases in activity of this isoenzyme would
indicate ineffective therapy. (19)
starkweather and associates (69) attempted to correlate
enzymatic aberrations with clinical evaluation of disease.

Their

results are summarized below:

: Extent of Disease--Clinical vs. Enzymatic Classification

i~---------1~R~f:;1c~~~y~~:a~r6n_i-N;;~~r

i

-.

Clinical
I Total LDH and iso- ' Isoenzyme patj Total LDH & Iso,
Classificati0nl enzyme pattern(27) tern only(12)1 enzyme pattern(ql

L·-"-"-----'"--·-'---"-----·--"l---"---~------~ "-"--/

Extensive
Limi ted

I

!
I

! ..-------"---,----------

25

10

2

2

4

None of the patients with abnormal total serum LDR demonstrated
normal isoenzyme patterns.

In the four "clinically extensive"

but enzymatically normal patients, the enzyme nattern became
abnormal within five days to four weeks after admission to the
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study.

Thus, the use of such

~arameters

as a screening test for

the early detection of neoplastic disease does not appear to
possess adequate sensitivity to be of clinical use.
Elhilali and associates (14) nroposed the use of LDH 1soenzymes in the differentiation of hyperplasia and carcinoma of
the prostate.

Prostatic fluid was examined and prostatic tissue

frDm transuretbral resection, prostatectomy and needle biopsy were
obtained.

A shift to slower migrating isoenzymes was demonstrated

in tissue specimans from patients with carcinoma; only normal prostatic fluid isoenzyme levels were established, although in three
cases of carcinoma studied, the isoenzyme patterns were abnormal.
Since it is estimated that 95% of the patients with carcinoma of
the postate are disgnosed too late for operative treatment, an
earlier method of detection would certainly be advantageous.

Such

a method is proposed; that is a screening test which would involve
a study of the LDH isoenzymes of prostatic fluid.

In cases of

early carcinoma this would be practical, however in advanced
carcinoma of the prostate, fluid is difficult to obtair.•

Another

apnlication of LDH isoenzymes would be to monitor changes in the
sera of patients with advanced carcinoma under treatment as an
index of the efficacy of that treatment. (14)
Starkweather and associates (69) proposed the determination
of LDH isoenzyme responses following therapy for neoplastic disease
as a prognostic guide.

(47, 7, 94)

Also proposing this plan were many others.

Of 21 patients who showed a decrease in the isoenzymes

complement (ascribed by those workers to the host's tumor), 12
improved either objectively or subjectively, 1 was unchanged and

7

grew worse.
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'rIlE EFFECT 0:3' OJ=L\.L CONTRACEPTIVr:S ON SERUM

El~ZYMES

Pulkkinen and 'Villman (56) studied 75 women taking estrogenic, progestogenic, combination, and sequential oral contraceptives and found no difference between that group and a group
of 30 controls.

They found that the total LDH activity in the

whole groun was decreased; however, estrogenic pills had no
effect on LDH; the progestagenic pills lowered the activity of
LDH but did not

alte~

the isoenzymes.

The duration of adminis-

tration made no difference on the results obtained.

Administration

of a combination oral contraceptive to both men and W(men produced similar LDH serum changes, i,e, total LDH activity was lowered in 1-2 days following initiation of administration.

RECAPITULATION AND CONCLUSION
Lactic dehydrogenase which is present in all living cells,
plays an important role in glycolysis by catalyzing the reversible
conversion of lactate to pyruvate, producing in the process a
molecule of' reduced DPN.

Most workers believe there are five

electrophoretically distinct molecellar forms of LDI! otherwise
known as isoenzymes.

Each of the five isoenzymes is a tetramer:

that is it is composed of fou' subunits.

These four subunits

are of two basic types: the n M II or muscle-liver unit and the "H"
or heart unit.
IIMIl

LDH-I and LDH-5 are homogeneous, containing four

and four !tR" units, respectively, whereas LDH-2, LDH-3, and

LDH-4 are combinations of the two basic subunits~
The techniques used for identifying the LDH isoenzymes have
included the electrophoretic rate of migration in solid media and
the relative heat

~bility.

Electrophoretic demonstration of

isoenzyme activity is accomplished by conversion of neotetrazolium to

purple formazin by LDH production of DPNH.

Nomenclature is basea upon electrophoretic migration rates,
with the form having the highest mobility
designated as LDH-I.

toward~

the anode being

Thus, the hea.rt fraction is LDH-l and the

slowest or liver and skeletal muscle fraction is LDH-5.
more heat stable than the other isoenzymes.

LDH-l is

This property gives

rise to a heat stab1e test for isoenzymes which affords separation
of LDH activity into three categories:LDE-l; L:!2H-2,3,1+; and. LDH-5.
This activity is determined by measuring the declining optical
density as DPNH is diminishing and pyruvic acid concomitantly is
being reduced to lactic acid, or by the increasing optical density
as the reaction is proceeding in the reverse manner.
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Each tissue of the body elaborates its own uniaue pattern of
LDH isoenzymes.

LDH-l appears to predominate in aerobically func-

tioning tissues and is more efficient there than is LDH-5;

LDH~5

predominates in aerobically functioning tissues, where it is most
efficient.
Heart muscle is characterized by a predominance of LDH-I, followed in order by LDH-2, LDH-3, LDH-4 and LDH-5.

Liver shows a

nredominance of LDH-5 followed to a much lesser extent by LDH-4,
IJDH- 3, LDH-2 and LDH-l.
isoenzyme pattern.

Sl<eletal muscle resem.bles liver in its

Kidney shows a co-dominance of LDH-l and LDY"'.z

followed by LDH-3, I,DH-4 and LDB-5.

Lung shows predominance of

LDH-3, and to a lesser extent LDH-2 and LDH-4 are seen.

Pancreas

shows a predomin.ance of LDH- 3, followed closely by LDH-l and LDH-29
In g-ranulocytes LDH-5 predominates.
est in LDH-l and LDH-2;
LDH-5.

Mature erythrocytes are rich-

nucleated erythrocytes are richest in

Prostate, prostatic fluid, bone marrow, thyroid, adrenal,

spleen, brain, cervix, skin and stomach isoenzyme patterns are also
presented.

Normal human serum appears to be richest in LDH-2,

followed by LDH-l, I,DH- 3, LDH-4, and LDH-5.
~mny

factors influence the measured serum activity of an

enzyme--some of which are: rate of enzyme formation 2nd degradation
within a cell;

permeability of the cell membrane; rate of degrad-

ation in plasma or elimination in urine and bile; presence, absence
and relative concentrations of inhibitors, activators, co-factors
and substrate; and finally, the method of assay--all act together
to yield the final measured enzyme activity_
The serum pattern of LDH isoenzymes following organ injury

is usually characteristic of that organ.

IiiLyocardial infarction

produces an el.evation in serum LDH-l, which may be demonstrated
within a few hours of the acute attack, and persists for 5-10
days after all total plasma enzyme activities have returned to
normal.

Elevations in serum LDH-5 which have sometimes also

occurred have been ascribed to the presence of severe congestive
heart failure.

LDH isoenzymes can be used to differentiate

between myocardial infarction and congestive heart

failure~

acute

pericarditis, paroxysmal atrial fibrillation with stenocardia,
chronic angina pectoris, heart block with Stokes-Adams seizures,
acute venous thrombosis of the lower extremity and pulmonary
embolism.
In most cases of liver disease (including hepatitis, biliary
and fatty nutritional cirrhosis, biliary obstruction, and hepatic
metastasesJ the LDH abnormalitj most often encountered was elevation of the predominant isoenzyme found in hepatic cells,

LDE~5.

Pulmonary embolism produces inconsistent LDH-2,3,4 alterations and the main use of LDH isoenzymes would be to exclude
myocardial infarction.
Isoenzyme studies in anemia reveal LDH-l elevations in the
presence of hemolysis, LDH-5 elevations in megaloblastic or
hyperplastic marrow conditions, and no LDH-5 activity in aplastic
marrow conditions.
In muscle disease studies of muscle extracts show only that
a deficiency of LDH-5 constitutes a sign of some nonspecific
abnormality in the neuromuscular system.
In neoplastic disease the bigh rates of glycolysis charac-
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teristic of tunor cells with the concomitant shift to production
of LDH-5 which is

~ore

suited for pyruvate reduction accounts for

serum elevations of LDH-5 in neoplastic disease.

These elevations

have not been found until the tumor has reached a clinically
detectable size.

Therefore, at present the use of L.Dll isoenzyme

screening tests for early detection of neoplastic disease would
not appear to be of value.

LDll isoenzyme determinations may be

useful in several aspects of neoplastic disease, however.
zymes may differentiate malignant

effu0~ons

Isoen-

from benign.

Efficacy of anti-tumor therapy could be determined by monitoring
isoenzyme changes.

Early carcinoma of the prostate could be

detected by testing prostatic fluid or needle biopsy speciment.
Oral contraceptives

ap~ear

to have no effect on LDB isoen-

zyme patterns, although the total LDH serum activity may be
reduced by some preparations.
Fortunately, the applications of LDH isoenzyme determinations
are not to the diagnostician vvhat penicillin and cortisone were
once thought to be to the clinician.

Diagnosis and treatment of

ailments of ueop1e have not been reduced to a task capable of
being carried out by an automated analyzer and a computer.
Rather, it is a physiCian who, after eliciting a history and
examining the patient, selects a group of laboratory determinations
(which in certain instances this paper has tried to show would
include LDll isoenzymes) which may help him in confirming or
ruling out his clintcal impresstons; and then attempting to exulain such results on the basts of those clintcal impressions,
never losing sight of the :fact that he ts treating a .:2.§-tient

and not a laboratory result.

That is the clinical aD~lication

of LDE isoenzyme determination.
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APPENDIX
,--------

TISSUE
HEART

LIVER

LDH I SOEN 2YM": 1:'A'J'TERNS
OF NOHlvl11.L HUMAN TIS,3UES
% 1'C"NL LDH ACTIv~l'Y IN EACH ISOENZYME PEAK
LDH-5
LDH-4
LDH-3
LDH-2
LDH-1

-

-

24
35
26
36

3
13
;1.2
3

3
16
2

11

1

70
85
90

3
1
2
1

8
3
4
3

25
7

23
12
27

7

-

41
77
58
74

77
70
85
90

-

77
85
90

11

1

-7

16

5
21
14

16
27
7

79
41
43

43
33
38

44
34
32

12
24
15

1
7

-1

14
5
6

34
13
17

35
32

5
30

12
20

32,

21

11

37
27
32

12
32
15

49
27
43

2
9

-

-5

GRUmr,OCYTES

5
4

10
15

16
22

26
14

RBC'S &
HEl,WLYSATES

43
44
36
39

44
39
44
56

12
14
15

-

1
2
4
5

12
3

33
21

35
48

8

23

4
5

KIDNEY

I.UNG

PANCREAS

PROSTATE
PROSTATIC
FWID
BONE
MARROW'
THY':1.0ID

77

73
48
35
58

4
14

SKELETAL
MUSCLE

REF'.

-

77
70
90

-

77
70
90
77
70
90

2

Lf5

12
70

-

77

1

70
85

2
4

14

24

24

25

20

14

13

28

30

25

70

22

35

27

11

70
70

18

43

-2

13

70

--,--"~-'

ADRENAL

4

18

36

33

9

SPLEEN

5
9

14
27

29
33

32
20

20
5

BRAIN

25

29

31

14

1

70

:

70
90

CERVIX

8,

57

21

-

8

90

SKIN

-

4

34

37

25

29

31

23

25

17

4

4

15

31

30

21

55

31
23
33
32
44
23
44

37
48
47
39
46
55
41

21
18
16
24
8
15
12

7
7
3
3
1
5
3

4
3
2
2
1
1
0

43
85
87
59
74
25
75

STONlACH
FUNDIC
MUC0SA

PYLORIC
MUCOSA
SERUM

55 i

TABLE I
Summary of serum
and tissue LDH
isoenzyme patterns as reported
in the references
cited in the last
column"
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TABLE II

LDH I SO E}; zniE

:)IUT~AL

··TC)1'ii.L
LDH

HOUR

units

VA~T!\.l'TON

:\ 7~'
),
,1J

LDH I ;~()~N 2Yx/1ES

5

1

2

.240

27

38

20

8

7

1000

.312

28

38

19

7

8

1200

.288

26

.360

25

1600

.432

22

1800

.528

20

31

2000

.528

19

31

23

10

17

2200

10

11

2400

10

9

8

9

1400
•

" ".._

....,< •••• ~.~,_-.~,_."~,

H.

0200

d36

0400

.336

40

18

8

8

0600

.250

38

21

7

8

Table II. LDH isoenzyme diurnal variations in
a normal individual. (After Starkweather)(70).
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TABLE III
TYPICAL SERUM LDH I SOEN ZYM}~ PA'r'11 ERNS IN
PATIENTS \VITH ACUTE MYOCARDIAL INJ<"ARCTIONS (59)
-'"~''"'-''''''''''''''''''''~''.'''"'''''"'''''''''''''

PATIENT

ISOENZYMES

SGOT

B.J.

940

%".
3
3

E.J.

250

7

E.S.

234

22

H. :N.

32

8

Tr.

L.N.

147

37

416

42

9

Tr.

L.J.

88

22

296

37

1

Tr.

o. F.

226

30

491 :55

36

9

Tr.

M.R.

198

231

310

40

Tr.

Tr.

Tr.

1

Tr.

Tr.

units

;

58

4
Tr.

Tr.

I

~J~~~~tt-o-~~: t-;=;~i ::0 :i-:~9 .?~:
5

j'

:16- 32

0-6

i

0-4

~".'.

_J

Table III. Examples of serum LDH isoenzyme patterns of patients
with acute myocardial infarctions.(After Reusch and Bunch)(59)o
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. TABLE IV
r-,.."......_._._ _
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l>u ....
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-+, .... . . . .
,.~

i,'
\

r--T---'-;r---3-"-'Ij:--"-"~)""'-

-1

6
8
11
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27

I,
\
I
'
:
.

640! 48
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I:j 6
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30
31
22
18

27
28
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')0
I}
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33

33

61
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20

I

39
32
25

10
1
12
13
15

15
9
8
13

4
4
1]

7

q
3

4:
2
0
6
2.
12

22'
14
25
20
22
'14

0

2

26

0
0

1
4

160
20

24

20

25

13

8
3

1

22

0

18

9

3

0

84

2
7
5

3

30

8

25
25

44
42

33
31

26

29

11
17

14

22

q

5

Subendocardial

M.l.

.

r""-"-.....,--........--"'~,-~ 'fl~

"~~~"t'."'-"hl" "," """., " " "".", ... ~",..,.,., ,,,,~_.,,-,,,,,. ,u. c,.,. ",' ._ ..... _ _ ~ ....... ~.,-" ..... ~_.,_" ~.,"·--~"""~ .. ~""---~- ....

38
20

I

I

.j--~~.--.'

Ta ble IV. Examples of serial IJDR isoenzyme changes in
pa tients with acute myocardial infarction. (After 'Jroblewski and associates)(90).
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